Status:
COMPLETED
Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent
Lead Sponsor:
Scitech Produtos Medicos Ltda
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Post-marketing, prospective, multicentric, non-randomized registry to evaluate the safety and efficacy of Inspiron Sirolimus Eluting Coronary Stent at the treatment of "real-world" patients.
Detailed Description
Up to 5.0000 patients with native coronary arteries lesions with diameter between 2.5 and 4.0 mm and 34 mm of length treated solely with the Inspiron Sirolimus Eluting Coronary Stent. Stent implantat...
Eligibility Criteria
Inclusion
- alll patients that have been treated with the Inspiron Sirolimus Eluting Stent older and 18 years
Exclusion
- Safein Vein or Left Internal Mammary artery Grafts
Key Trial Info
Start Date :
June 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 21 2024
Estimated Enrollment :
2504 Patients enrolled
Trial Details
Trial ID
NCT03263260
Start Date
June 2 2017
End Date
January 21 2024
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
União Brasileira de Educação e Assistência - Hospital São Lucas da PUC - RS
Porto Alegre, Rio Grande do Sul, Brazil, 90.619-900